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Summary.-The injection (s.c. or i.p.) of 106 live or lethally irradiated methyl-
cholanthrene-induced fibrosarcoma cells into CBA/Ca mice one or 2 days before
i.v. challenge with the same tumour inhibited the formation of artificial lung tumour
metastases. In addition, it also frequently enhanced the cytostatic effect of peritoneal
exudate cells on monolayers ofthe same tumour. The effects on lung tumour meta-
stasis were not 'noted if X-irradiated tumour was injected i.v., or if s.c. admini-
stration was delayed until one day after i.v. challenge. Similar effects on tumour
growth were also observed in C3Hf/Bu mice and (CBA/Ca x A/HeJ) F1 hybrids which
were pretreated (s.c.) with tumour shortly before i.v. challenge with the same
tumour. Further studies in CBA/Ca mice suggested that the protective effect was
tumour-specific, for the growth ofi.v. injected tumour was not significantly inhibited
by pretreatment with a number of other MC-induced or spontaneous tumours from
the same and different strains.
A CONSIDERABLE number of investiga-
tions undertaken during recent years
have shown that factors which suppress
the function of lymphoreticular endothe-
lial cell may be released by or extracted
from a variety of tumours. For example,
factors have been reported which sup-
press (a) the in vitro response of spleen
cells to mitogens and alloantigens (De
Lustro and Argyris, 1976) and sheep
erythrocytes (Wong, Mankovitz and Ken-
nedy, 1974; Kamo et al., 1975); (b)
macrophage chemotaxis in vitro (Meltzer
and Stevenson, 1977a, b; Normann and
Sorkin, 1977; Snydermann and Pike, 1976;
Pike and Snydermann, 1976) and in vivo
(Snyderman and Pike, 1976; Pike and
Snyderman, 1976); (c) macrophage-
mediated resistance to infection (North,
Kirstein and Tuttle, 1976a, b); and (d)
the in vivo response to syngeneic (North et
al., 1976b; Pike and Snyderman, 1976;
Nelson and Nelson, 1977) and allogeneic
(Bonmassar et al., 1973) tumour trans-
plants. It would also appear that the
inhibitory effects observed in vivo are not
always dependent upon the presence of a
large tumour mass, for they may be
evident within 24 h ofthe s.c. transplanta-
tion of 106 tumour cells (North et al.,
1976a, b).
The observed effects on macrophage
function have led to the suggestion that
neoplastic cells may abrogate or interfere
with the early phases of immunosurveil-
lance by releasing products which modify
the localization and/or activity of macro-
phages (Snyderman and Pike, 1976; Pike
and Snyderman, 1976; North et at.,
1976a, b; Nelson and Nelson, 1977). In
view of the above suggestions and the
observations of North et al. (1976a, b), we
thought it was important to establish
whether the injection ofsyngeneic tumour
cells shortly before i.v. challenge with the
same tumour cells would increase the
incidence of artificial metastases, or inter-
fere with the capacity of macrophages to
exert a cytostatic effect on syngeneic
target cells in vitro. Contrary to expecta-
tions we found that the injection of
syngeneic tumour cells as late as 1 dayK. JAMES, R. T. CULLEN, 1. MILNE AND M. NORVAL
before i.v. challenge inhibited the develop-
ment of artificial metastases. It had,
however, a less consistent effect upon the
cytostatic activity of peritoneal exudate
cells harvested within 2 days of tumour
injection.
MATERIALS AN!) METHODS
Mice.-Almost all the experiments wvere
performed in inbred CBA/Ca mice (male and
female) aged 8-12 weeks. The remaining
experiments wvere undertaken either in F1
hybrids of CBA/Ca and A/HeJ mice or inbred
C3Hf/Bu mice. The CBA/Ca mice were bred
from mice obtained from the MRC Laboratory
Animals Centre, Carshalton, Surrey. The
A/HeJ mice used in the breeding of the
(CBA/Ca X A/HeJ) F1 hybrids were pur-
chased from the Jackson Laboratories, Bar
Harbor, Maine, U.S.A. The C3Hf/Bu mice
were derived from stock originally obtained
from Baylor University, Texas, U.S.A. They
were kindly provided by Dr W. H. McBride
of the Department of Bacteriology, Univer-
sity of Edinburgh.
Tumours.-A number of tumours were
used in these studies. They include (a) MC
fibrosarcomas from a number of strains of
mice; (b) a fibrosarcoma which had been
obtained by injecting CBA/Ca mice with
syngeneic embryo cells which had trans-
formed in vitro; and (c) an adenocarcinoma
which had spontaneously appeared in CBA/Ca
mice. Further details on the origin, generation
number and designation of these tumours
are presented in Table I.
Cultured MC-induced CBA fibrosarcoma
cells (CCH1) were generally used for pre-
treatment and always used for challenge.
These cells had been maintained for 3-18
months in culture, as previously described
(Ghaffar et al., 1974). The T3 fibrosarcoma
cell line was also maintained in culture. All
the other tumour-cell suspensions used were
obtained by pronase digestion of freshly
excised tumour cells (Woodruff and Boak,
1966).
X-Irradiation.-Tumour cells were irradia-
ted at a dose rate of 274 rad/min to a total
of 22,000 rad using a Westinghouse X-ray
machine operating at 220 kV and 15mA, with
HVL of 1 2 Cu under conditions ofmaximum
backscatter.
In vivo experimental model.-The basic
protocol involved injecting mice s.c. with 106
syngeneic or allogeneic tumour cells 1 to 2
days before i.v. challengewvith 5 x 104tumour
cells. The mice were killed 14 days after
challenge, the lungs removed and fixed in
Bouin's solution and the number of artificial
metastases (tumour nodules) per lung
counted. Each experimental group contained
6 to 19 mice. Further details on variations in
this basic protocol are reported elsewhere in
the text or in the footnotes to the figures and
tables.
In vitro cytostatic assay.-The procedure
used has been described in greater detail
elsewhere (Ghaffar et al., 1974). In essence
it involved the addition of test effector cells
to tumour-cell monolayers in the wells of
plastic microculture plates and incubating the
plates at 37°C for 48 b. At this stage, the
culture medium (see below) was replaced by
fresh medium containing 1251-iododeoxyuri-
dine (Radiochemical Centre, Amersham,
England). The incorporationofthisthymidine
analogue into the tumour-cell monolayer was
assessed 20 h later in an LKB WVallac gamma
scintillometer. The spleen cells whose cyto-
static activity was being assessed wvere obtain-
ed by gentle disruption in cold medium in a
hand-operated glass homogenizer while the
peritoneal exudate cells w%ere obtained by
washing out the peritoneal cavity with 3 ml
of medium containing 10 u of heparin/ml.
These cells were alw%Aays washed x 3 before
use. Throughout these in vitro studies, the
medium used was RPMI 1640 (Gibco Biocult,
Paisley, Scotland) buffered with 20 mm
HEPES and supplemented with 10% (vol/
vol) foetal calf serum, 100 u/ml penicillin and
100 ,ug/ml streptomycin.
Bacteriological and virological investiga-
tions.-A variety of standard procedures
were used to ascertain if the cultured CBA
MC fibrosarcoma cell line routinely used in
these studies (that is, CCH1) was contamina-
ted with micro-organisms which might in-
fluence antitumour responses. In brief these
included electronmicroscopic examination of
tumour cell sections, the screening of cells
and culture supernatants for mycoplasma
(McKay et al., 1974), reverse transcriptase
assays using the method of Dr Natalie Teich
(personal communication) and indirect im-
munofluorescence on acetone-fixed cells (Hart
and Marmion, 1977) with antisera to
Moloney leukaemia virus and RD-114, an
endogenous feline RNA oncovirus. Finally,
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the cells wvere grown in the presence of
3H-uridine and the supernatants screened
for the presence of micro-organisms contain-
ing RNA. Further details on the culture
procedure and the density-gradient separa-
tion technique used in the incorporation
studies are reported elsewhere (Norval and
Marmion, 1976).
Presentation of results.-The number of
artificial metastases observed in experimental
mice have been presented in scattergram
form and the significance of the results has
been determined using the Wilcoxon Rank
Sum test. The in vitro cytostatic results have
been expressed as geometric means together
with the limits of one standard error from
the mean ct/min of 5 replicate samples. The
cytostatic indices (CI) have been calculated
using the following formula:
cr (N -T) x 100 N
where N represents the mean ct/min obtained
using effector cells from untreated (control)
mice, and T represents the mean ct/min
using effector cells from mice treated with
tumour cells. The significance of the cyto-
staticresultshasbeenassessed bythestandard
Student's two-tail t test.
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RESULTS
The effect of the preinjection of tumour cells
on the development of artificial lung
metastases
In our- initial experiments, mice were
injected s.c. with 106 viable cultured
tumour cells and challenged i.v. 24 h later
with various doses of cultured syngeneic
tumour cells. The number of artificially
induced pulmonary metastases present
14 days later was determined. The results
of one such experiment are presented in
Fig. 1. It will be noted that the number of
metastases was significantly reduced in
mice which had been injected s.c. with
syngeneic tumour cells 24 h before i.v.
challenge.
These initial observations were un-
expected in view of previous suggestions
that such pretreatment might interfere
with the antitumour activity of host
macrophages (for example see North et al.,
FIc. 1. The effect on the growth of i.v.
injecte(i tumour cells of the preinjection
(s.c.) of syngeneic tumour cells. A, C-no
pretreatment; B, D-tumour cells s.c.
Mice were pretreated by s.c. injection with
106 cultured syngeneic MC fibrosarcoma
cells (CCH1) 24h before i.v. challenge with
5 x 104 or 1 x 105 CCHI tumour cells.
Note that 14 days after i.v. challenge the
number oflung metastases in the pretreated
groups (B and D) was significantly lower
(P<0-01) than in groups receiving no pre-
treatment (A andl C).
1976a, b). We decided therefore to perform
additional experiments to see whether the
effect observed was dependent upon the
dose and route of injection of the tumour
cells, the time they were injected in rela-
tion to i.v. challenge, and whether or not a
similar effect could be achieved with
lethally irradiated syngeneic tumour cells
or with other syngeneic and allogeneic
tumours.
Several experiments were performed to
determine the dose dependency of the
- - .
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FIG. 2. The effects on the growth of i.v.
injected tumour cells of the preinjectioni
(s.c.) of various doses of syngeneic tumour
cells. Mice in Groups B, C and D were
injectedl respectively s.c. with 107, 106 and
104 cultured syngeneic MC fibrosarcoma
cells (CCHI) 24 h before i.v. challenge
with 5 x 104 CCH1 tumour cells. Group A
mice had no pretreatment. Note that 14 days
after i.v. challenge the number of meta-
stases in animals pretreatecl with 107 (B)
and 106 (C) tumour cells was significantly
lower (P<0-01) than in mice receiving no
pretreatment (A). The inhibition observed
in animals pretreated with 104 tumour
cells (D) wasjust significant at the 0-05 level.
effect, and the results of one of these
experiments are presented in Fig. 2. These
studies revealed that 106 tumour cells or
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Fi(-e. 3. The effects o'i the growth of Lv.
injected ttumouir cells of the prelinjection
(s.c.) of various tumour cell preparationls.
All mice received i.v. challenge with 5 x 104
cultuired CCH1 fibrosarcoma cells. Pretreat-
ment: A-no pretreatment; B syngeneic
MC fibrosarcoma cells Day -I; C-
lethally irradiated syngeneic MC fibrosar-
coma cells Day -1; D syngeneic MC
fibrosarcoma cells Day +1; E allogeneic
MC fibrosarcoma cells Day -1. Syngeneic
MC fibrosarcoma cells were fiom culture(d
CCH 1. Allogeneic MC fibrosarcoma cells
were from freshly excised ACH3. Note that
14 days after challenge the number of
tumour metastases per lung was signifi-
cantly lower in mice pretreate.d with viable
or lethally irradiated syngeneic tumour cells
(B and C, P<0 01). In contiast, pretreat-
ment with allogeneic tumour cells or the
administration of tumour cells after i.v.
challenge did not inhibit tumour meta-
stases. (For further results of a similar
nature see Figs. 5 and 7.) ---
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more had to be injected s.c. to ensure
effective inhibition metastasis.
Experiments were then undertaken to
see whether the protection observed
above could also be achieved by pre-
injection ofX-irradiated syngeneic tumour
cells or allogeneic MC fibrosarcoma cells of
A/HeJ origin. These studies revealed that
the preinjection of X-irradiated syngeneic
tumour cells also inhibited the develop-
ment of artificial metastases following i.v.
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Fic. 4.--The effects on the grovth of i.v.
injectecl tumour cells of the preinjection
of X-irradiated syngeneic tumour cells by
different routes. Mice B-D were injected
by the route indicated with 106 lethally
irradiated cultured syngeneic MC fibro-
sarcoma cells (CCH1) and were challenged
i.v. 2 (lays later with 5 x 104 CCH1
tunmour cells. Note that 14 days after
challenge the number of lung metastases
in the s.c. (B) and i.p. (C) pretreatedl
groups were significantly lower (P<0 01)
than in the control group (A), while those
in the i.v. pretreated group (D) were not
significantly different (P<0 01).
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Fio. 5. The effect on the grow th of i.v.
injecte(l tumour cells of the s.c. injection
of syngeneic tumour cells. Mice in Grotups
B-F were injecte(d s.c. with 106 culture(d
synigeneic MC fibrosarcoma cells (CCH 1)
at various times (Day -3 to Day + I
respectively) in relation to challenge i.v.
with 5 x 104 CCH1 tumour cells. Note
that the number of tumour metastases
14 days after i.v. challenge was significantly
reduced (P<0.01) in the pretreated groups
(B-D) but was not significantly affecte(d in
animals injected at the same time (E)
or 24 h after i.v. challenge (F). See also
Fig. 3, (D).
challenge, whilst pretreatment with fibro-
sarcoma cells of A/HeJ origin (designated
ACH3) was without effect. It should also
be noted that syngeneic tumour cells
failed to inhibit tumour growth if admini-
stered after i.v. challenge. This pheno-
menon was investigated further (see
Fig. 5).
Investigations were then made into
whether the protective effect afforded by
preinjection of syngeneic tumour cells
shortly before challenge was dependent
upon the route of administration of the
original inoculum. In this experiment
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FIG. 6. The effects on the growth of i.v.
injected tumour cells of the preinjection
(s.c.) of syngeneic tumour cells. Mice in
Groups B-D were injected s.c. with 106
cultured syngeneic MC fibrosarcoma cells
(CCHI) at various times (Days -14, -7
and -2 respectively) in relation to i.v.
challenge with 5 x 104 CCH 1 tumour
cells. Note that the number of tumour
metastases observed 14 days after i.v.
challenge was significantly decreased in all
pretreated groups (P<0 05 to P<0-01).
mice were injected s.c., i.p. or i.v. with
106 irradiated tumour cells. Significant
inhibition of pulmonary metastasis was
noted following preinjection by the s.c.
and i.p. routes, but not by the i.v. route
(see Fig. 4). This effect has been observed
on 3 separate occasions.
The next 2 experiments were prompted
by previous observations that the pre- .~~~~~~~~~~~~~~~~~~~~~~~~~~~~~)r
C2:
P
0
z En
:
En
H
A B C D E
FiC,. 7. The effect on the growth of i.v.
injectedl MC fibrosarcoma cells of the
preinjection (s.c.) of various tumour cells.
Mice were injected s.c. with 106 viable cells
from a variety of freshly excised tumours
and challenged i.v. 48 h later with 5 x 104
cultured MC fibrosarcoma cells (CCH1).
Pretreatment: A no pretreatment: B-
syngeneic MC fibrosarcoma (CCHI); C-
syngeneic spontaneous tumour (W54);
D allogeneic MC fibrosarcoma (ACH3);
E allogeneic MC fibrosarcoma (FSA).
Note that 14 days after challenge the only
significant reduction in lung metastasis was
observed in mice pretreated with CCH1
tumour (B, P<0-01). On this occasion
the spontaneous tumour (W54, C) also
inhibited tumour growth, though the
effect was not significant, and in the 7
additional experiments performed with
this tumour the inhibitory effects were
much less marked.
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TABLE I.-A Summary of the Effects ofPreinjection* (s.c.) of Various Tumours on the
Growth in CBA Mice of a Syngeneic MC Fibrosarcoma (CCH1) Injected
(i.v.) 24-48 h Later
The tumours preinjected
Description Tumour
designa-
tion
Genera-
tion
Nos.
Strain of
origin
How induced
Fibrosarcoma CCH1 18-19 CBA/Ca With 3 methylcholanthrenet
(Woodruff, Inchley and
Dunbar, 1972)
Fibrosarcoma CCH5 1-2 CBA/Ca With 3 methylcholanthrene
(Woodruff et al., 1972)
Fibrosarcoma T3 ¶ CBA/p By injection of embryo cells
spontaneously transformed
in vitro (Smith and Scott,
1972)
Adenocarci- W54 4-5 CBA/Ca Spontaneous origin
noma (Woodruff and Whitehead,
1977) (in preparation)
Fibrosarcoma ACH3 26-27 A/HeJ With 3 methylcholanthrene
(Woodruff et al., 1972)
Fibrosarcoma FSA 6 C3Hf/Bu With 3 methylcholanthrene
(Suit and Suchato, 1967)
Times
inhibited/
times
testedt
20§/28
0/3
0/1
0/8
0/8
0/3
* Mice were injected s.c. with 106 viable tumour cells and 24-48 h later challenged i.v. with 5 x 14
viable CCHI fibrosarcoma cells.
t The number ofexperiments in which significant inhibition (P<0-05) of lung metastases formation was
observed out of the total number of experiments performed.
t This tumour is highly immunogenic, a single inoculum of 106 irradiated cells (22,000 rad) conferring
complete protection to mice challenged 2 weeks later with 104 viable tumour cells (Woodruff and Dunbar,
1973).
§ In all 28 experiments the growth of tumour was inhibited, but this inhibition failed to reach significant
levels in 8 experiments. On all these occasions a suspension of freshly excised tumour cells had been injected.
¶ Maintained in culture.
Note: Significant inhibition of growth of i.v.-injected cultured CCHI tumour cells is only achieved after
preinjection of CCHI tumour cells.
ence of s.c. growing tumour reduced the
number of artificial pulmonary metastases
which could be induced by the i.v.
injection of syngeneic tumour cells (Milas
et at., 1974). These workers also demon-
strated by adoptive transfer that the
resistance conferred was immunologically
mediated, protectionbeingmosteffectively
transferred by cells from mice challenged
12 days previously with viable tumour
cells. We decided therefore to investigate
in more detail the development ofartificial
pulmonary metastases in mice which had
been injected s.c. with syngeneic tumour
cells at various times before and after i.v.
challenge.
The initial "short-term" pretreatment
experiment involved injecting mice s.c.
with 106 viable syngeneic tumour cells on
either Day -3, -2, -1, 0 or +1 in
relation to i.v. challenge with 5 x 104
tumour cells, and 2 weeks after challenge
the number oflung metastases formed was
assessed. Significant suppression of meta-
stasis was observed in all mice pretreated
with syngeneic tumour cells, but was not
achieved in mice treated after i.v. chal-
lenge (Fig. 5), thus confirming our pre-
liminary observation (Fig. 3).
A further experiment was performed
in which mice were injected s.c. with 106
viable syngeneic tumour cells 14, 7 and
2 days before i.v. challenge. A significant
reduction in pulmonary metastasis was
noted following pretreatment at all these
times.
The specificity of the protection con-
ferred was assessed by pretreating the
CBA mice with a variety of tumours of
syngeneic and allogeneic origin. The
results of one such experiment are shown
in Fig. 7. It will be observed that pretreat-
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Fie. 8. The effect on the growth of i.v.
injected tumour cells of the preinjection
of tumour cells s.c. In these experiments
C3Hf/Bu mice were injected s.c. with 107
viablecultured syngeneic tumourcells(FSA)
and challenged i.v. 1 day later with 105 of
the same tumour cells. The (CBA/Ca x
A/HeJ) F, hybrid mice on the other
hand were pretreated with 106 cultured
viable MC fibrosarcoma cells of CBA/Ca
origin (CCH1) and challenged i.v. 1 day
later with 5 x 104 CCH1 tumour cells.
Note that 14 days after challenge the
number of artificial metastases in the
tumour pretreated groups (B) were signi-
ficantly less (P< 0-01) than in the un-
treated controls (A).
ment with only the syngeneic MC fibro-
sarcoma (CCHI1) significantly inhibited
the formation of artificial metastases
following i.v. challenge with CCHI1. The
specificity ofthis phenomenon was further
confirmed in a whole series ofexperiments,
the results of which are summarized in
Table I. It should be noted that to date
we have failed (despite repeated testing)
to significantly inhibit the growth of the
CCHI1 fibrosarcoma by pretreatment with
other syngeneic and allogeneic MC fibro-
sarcomas and a syngeneic tumour of
spontaneous origin.
In order to ensure that the phenomenon
observed was not unique to the CBA/
CCIH1 combination, experiments of a
similar nature were performed in C3H
mice with syngeneic MC fibrosarcoma
(FSA) and in (CBA/Ca x A/HeJ) F1
hybrid mice using the CCH1 tumour.
These experiments revealed (Fig. 8) that
similar effects to those noted above could
be obtained in other mouse tumour
combinations.
A number of other interesting points
emerged during the course ofthese studies:
(a) similar protective effects could be
achieved following pretreatment (in Day
2) with UV-irradiated cultured CCH1
tumour cells; (b) the tumours which
developed in protected mice were much
smaller than those observed in control
mice; (c) tumour metastases were not
observed in extrapleural sites; and (d)
preliminary studies indicated that pre-
injection of cultured CCHI1 tumour cells
did not influence the clearance of 125J-
labelledPVP or51Cr-labelledCCH1 tumour
cells injected one or 2 days later.
Finally, an overall analysis ofthe effects
achieved by pretreatment with CCH1
tumour cellsrevealedthat cultured tumour
cells were much more effective than
freshly excised tumour cells. Significant
protection was observed in all experiments
(17/17) involving pretreatment with cul-
tured CCH1 tumour cells, but in only 3/11
experiments with freshly excised CCH 1
cells.
The effect ofpreinjection of tumour cells on
the in vitro cytostatic activity of peritoneal
and other cells
In these studies mice were usually
injected s.c. with 106 cultured, syngeneic
MC-induced fibrosarcoma cells (CCHI1)
and 24 or 48 h later the cytostatic effect
of their peritoneal exudate cells (PEC),
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TABLE II.-Effect of Preinjection (s.c.) of Untreated or X-irradiated Syngeneic
Fibrosarcoma Cells (CCH1) on the Cytostatic Activity ofPeritoneal Exudate
Cells on CCH1 Target Cells
Mouse treatment
(Day-1)
0.1 ml Saline s.c.
106 Syngeneic MC fibro-
sarcoma cells s.c.
106 X-irradiated (22 krad)
syngeneic MC fibro-
sarcoma cells s.c.
Effector:
target
ratio
80:1
40:1
20:1
80:1
40:1
20:1
80:1
40:1
20:1
In vitro tumour control
ct/min
(Geometric mean of 5 replicates)*
74,110 (69,924-78,546)
99,029 (90,502-108,360)
103,082 (100,612-105,613)
45,843 (37,658-55,807)
98,221 (97,415-99,034)
109,911 (102,725-117,599)
59,977 (58,046-61,972)
97,017 (95,023-99,052)
93,890 (91,541-96,300)
98,093 (94,911-101,382)
* Figures in pareintheses represent mean ±s.e.
t 2-tailed Student's t test comparison of test groups with saline control. Values of P>0.05 were con-
sidered not significant (NS).
Note: Increased cytostasis following injection with non-irradiated and lethally irradiated tumour cells
apparent with the 80: 1 effector:target ratio.
TABLE III.-In vitro Cytostatic Activity of PEC*: Effect of Removing Glass-adherent
Population
Mouse treatment
(Day-2)
0-1 ml saline s.c.
106 Syngeneic MC fibro-
sarcoma cells (CCH1) s.c.
In vitro tumour control
Effector:
target
ratio
80:1
40:1
ct/min (Geom. mean ± s.e.)
Whole PEC
2,494 (2,368-2,627)
21,486 (20,384-22,648)
80:1 446 (353-562)
40:1 14,447 (13,398-15,578)
Non-adherentt PEC
15,534 (14,699-16,416)
27,901 (27,153-28,670)
14,701 (13,514-15,991)
28,291 (27,977-28,609)
36,435 (33,945-39,109)
* Peritoneal exudate cells.
t Adherent cells removed by incubating PEC in large tissue-culture flasks for 1 h.
Note: The marked reduction in the cytostatic effect of PEC on CCH1 tumour monolayers after removal of
glass-adherent cells. This was apparent with PEC from both saline controls and tumour-pretreated mice.
spleen cells etc. on monolayers of the
same tumour was assessed. In the majority
of experiments, this short-term pretreat-
ment produced a significant increase in the
cytostatic activity of peritoneal exudate
cells. Results from a typical experiment
are presented in Table II. It was generally
found that PEC from control mice express
a cytostatic effect at the higher effector-to-
target ratios and that preinjection with
tumour increases this effect. It will also be
observed that lethally irradiated tumour
cells were also capable of stimulating the
cytostatic activity of PEC. To date, no
effect on the antitumour activity of cells
from peripheral blood, spleen and lymph-
node cells has been observed using this
short-term tumour pretreatment (data
not shown).
The cytostatic component of both
normal PEC and tumour-stimulated PEC
appeared to be associated with a glass-
adherent population (Table III). This
would suggest thatthe effects are mediated
by macrophages but this will require
confirmation by further analysis.
Further studies revealed that the in-
creased cytostatic activity of PEC after
injection with syngeneic tumour (CCH1)
could also be achieved using an allogeneic
Pt
<0 05
NS
NS
<0-02
NS
<0-05
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TABLE IV. Effect ofPreinjection (s.c.) of Various Turnours on the In vitro Cytostatic
Activity ofPEC on CCHI Tumour Monolayers
Mouse treatment
(Day -2)
0-1 ml Saline? s.c.
106 Syngeneic MIC fibro-
sarcoma cells (CCH1) s.c.
106 Allogenieic MC fibro-
sarcoma cells (ACH3) s.c.
106 Syngeneic spontaineouis
adenocarcinoma cells
(W54) s.c.
In eitro tumour control
Effector:
target
ratio
80:1
40: 1
20:1
ct/min (Geom. mean of 6 replicates t s..)
Expt. i
15,472 (14,274-16,771)
42,774 (41,859-43,710)
39,941 (38,876-41,037)
80:1 565 (502-637)*
40:1 15,874 (15,199-16,578)*
20:1 39,173 (38,788-39,562)
80:1 2,700 (2,305-3,163)*
40:1 33,934 (33,252-34,631)*
20:1 38,715 (38,240-39,195)
80 :1 33,420 (32,753-34,100)t
40:1 38,036 (37,515-38,564)*
20:1 38,109 (37,401-38,830)
44,032 (43,502-44,570)
Expt. 2
345 (334-356)
1,975 (1,769-2,206)
12,888 (11,625-14,288)
866 (691-1,086)t
21,927 (20,390-23,580)t
39,221 (38,245-40,222)t
434 (406-464)t
5,732 (4,882-6,731)t
36,195 (34,183-38,326)t
3,055 (2,684-3,503)t
28,082 (27,041-29,163)t
41,195 (39,563--42,894)t
41,54'3
Notes: Expt. 1.-Treatment with both the syngeneic and allogeneic fibrosarcomas results in elevation of
cytostasis at the higher effector: target ratios. Treatment with spontaneous tumour abrogate(d the cytostatic
activity of PEC.
Expt. 2.-Marked anti-tumour effect of the saline control PEC. All tumour pre-treatments reducedi this
effect, particularly noticeable at the effector: target ratios of 40: 1 and 20: 1. As in Expt. 1, the spontaneous
tumouir was most effective in reducing the cytostatic activity of PEC.
Statisticaql significance: All tumouir-treated groups compared with saline contiols using a 2-tailedi Stuident's
t test.
* Significantly lower (P<0-01) than in control group.
t Significantly greatei (P<0-02) than in control group.
MC fibrosarcoma of C3H origin (Expt. 1,
Table IV). It was not observed, however,
following pretreatment with a spontaneous
syngeneic tumour (W54). On the contrary,
treatment with the spontaneous tumour
resulted in a marked decrease in cyto-
stasis.
Abrogation or reduction of cytostasis
has also been observed in a minority of
experiments with the syngeneic and allo-
geneic MC fibrosarcomas (Expt. 2, Table
IV) and appears to be associated with an
extremely high cytostatic activity in the
PEC of control mice. Such high levels of
activity may be due to transient infection
in the mouse colony, leading to stimulation
of the lymphoreticular system as des-
cribed by Hibbs, Lambert and Remington
(1972) and Krahenbuhl and Remington
(1974).
Finally, it should perhaps be noted that
the marked cytotoxicity normally elicited
in PEC after i.p. C. parvum was not
affected by injecting syngeneic MC fibro-
sarcoma cells (s.c.) one day before C.
parvum injection (data not shown).
Bacteriological and virological studies
Four separate cultures of CCH1 have
been examined. Three of the preparations
were routinely used in these studies for
pretreatment and challenge and they
have been maintained in culture for 3-18
months. The remaining sample had been
cultured for only a week.
To date there has been no evidence of
contamination with micro-organisms in
any of these preparations. No bacteria,
mycoplasmas, viruses or virus-like parti-
cles were observed on electronmicroscopy
of ultra-thin sections of tumour cells, and
no mycoplasmas or bacteria were isolated
by culture techniques. Density gradient
ultra-centrifugation of 3H-uridine-labelled
culture supernatants failed to reveal any
radioactivity banding in the positions
characteristic of bacteria, mycoplasmas
(density 1.22) lactic dehydrogenase-elevat-
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ing virus (density 1.17) or RNA oncovirus
(density 1e16-1e18). Furthermore there
was no evidence of reverse-transcriptase
activity in tumour-cell-culture superna-
tants. Finally, immunofluorescence tests
with antisera to MLV and RD-I 14 also
proved negative.
DISCUSSION
The present experiments clearly demon-
strate that the preinjection (s.c. or i.p.)
oflive or lethally irradiated CCH1 methyl-
cholanthrene-induced tumour cells into
CBA/Ca mice shortly before challenge i.v.
with the same tumour severely impaired
the development of artificially induced
lung metastases. In addition, peritoneal
exudate cells recovered from mice in-
jected one or 2 days previously with such
tumour cells frequently exhibited an
elevated in vitro cytostatic effect on
syngeneic MC fibrosarcoma cells. The
effects of lung metastasis were not readily
achieved when small doses of cells (i.e.
<105) were used in the pretreatment,
when they were administered i.v., or
if they were injected the day following
antigenic challenge. The experiments also
suggest that the in vivo protective effects
are probably specific, significant protection
only being conferred when the mice were
pretreated with the same tumour as used
for challenge. Furthermore, similar pro-
tective effects were noted in other mouse-
tumour combinations.
The present observations are similar
in certain respects to those noted in less
extensive studies from other laboratories
(Milas et al., 1974; Yuhas, Pazmino and
Wagner, 1975; McBride, personal com-
munication). They differ, however, from
those recently reported by other investiga-
tors in other models (North et al., 1976;
Pike and Snyderman, 1976; Nelson and
Nelson, 1977) and are difficult to reconcile
with previous suggestions that the initial
survival of tumours may be due to their
ability to suppress macrophage-mediated
surveillance mechanisms (North et al.,
1976a, l; Nelson and Nelson, 1977; Pike
and Snyderman, 1976; Snyderman and
Pike, 1976).
At the present time, the mechanism
whereby the preinjection of tumour-cells
can inhibit the growth ofthe same tumour
injected i.v. only one or 2 days later
remains to be established. However,
observations in other tumour systems
suggest a number of ways in which this
rapid effect might be achieved. In the
first place, the injection ofvarious tumours
has been found to result in the appearance
within one day of suppressor T cells
(Fujimoto, Greene and Sehon, 1976), whilst
cytotoxic cell activity was apparent within
3 days of challenge (Schick and Berke,
1976). Others have also shown that the
injection of tumours or tumour-cell
extracts in rats induces within 2 days
mitosis in sinus macrophages in the
draining lymph nodes and a peripheral
blood monocytosis (Carr, Price and
Westby, 1976). Additional studies had
revealed that the ability of tumour to
produce monocytosis appears to be directly
related to its antigenicity (Eccles, Bandlow
and Alexander, 1976). Thus, in theory at
least, the effect might be due to a rapidly
induced increase in T-cell cytoxicity or
macrophage activity. Alternatively, if the
initial growth of tumours is dependent
upon immunostimulation (see Prehn,
1976) it might be due to the rapid develop-
ment of suppressor T cells. In addition,
the possibility of a prompt effect of
natural killer (NK) cell activity cannot
be excluded.
The observation that pretreatment with
cultured tumour cells results in more
effective protection than similar pretreat-
ment with freshly excised tumour cells
is of interest. There are several possible,
though yet untested, explanations for this
difference. For example, the normal host
response to i.v. challenge may have been
adversely influenced by any lymphoreti-
cular cells which might have been present
in freshly excised tumour cell suspensions.
Alternatively, the tumour cells may have
undergone modification during culture
and as a result become more effective at
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stimulating host defence mechanisms.
Such mechanisms might include the aqui-
sition of new tumour-specific transplant
antigens or foetal calf serum antigens
from the culture medium.
Our extensive bacteriological and viro-
logical investigations, together with the
fact that the effect can be achieved with
UV-irradiated cells, leads us to conclude
that our observations are probably not
due to contamination with micro-
organisms such as the LDH virus which
is known to be present in many tumours
(Riley, 1968) and has been found to
modulate the immune response of the
tumour-bearing host (Kamo, Patel and
Friedman, 1976). In any case it is known
that the LDH virus, which replicates in
macrophages (Kamo et al., 1976), does not
usually survive for more than 10 days in
culture. Indeed this property is exploited
to remove the virus from infected tumours
(Riley, 1968). Nevertheless, the possibility
still remains that the effect is due to
contamination with some as yet un-
detected virus such as the minute virus of
mice which has recently been shown to be
responsible for the immunosuppressive
effects of mouse EL-4 lymphoma cells
on the mixed lymphocyte reaction (Bon-
nard et al., 1976).
The present results are of particular
interest in view of the recent flourish of
reports indicating that tumours and
tumour-cell products may interfere with
the development and activity of cells of
the monocyte macrophage series (see
introduction and James, 1977). These
observations have led to the suggestion
that tumours may initially become estab-
lished by suppressing macrophage-media-
ted surveillance mechanisms (North et al.,
1976a, b; Snyderman and Pike, 1976;
Pike and Snyderman, 1976; Nelson and
Nelson, 1977). The present observations,
however, emphasize that the picture is far
more complicated than suggested above,
for pretreatment with tumour may on
occasions inhibit rather than promote the
growth of tumour injected shortly after-
wards. In addition there is also a number
of reports indicating that tumours may
actually stimulate macrophage develop-
ment and activity, these effects being
noted within 2-3 days of tumour chal-
lenge (James, 1977). It is obvious that the
effects of tumour on macrophage function
are complex and diverse. Indeed it has
recently been shown that short-term
pretreatment with tumour may inhibit the
chemotactic responses ofperitoneal macro-
phages whilst simultaneously enhancing
their capacity to phagocytose antibody-
coated shieep erythrocytes (Meltzer and
Stevenson, 1977a). Furthermore, it is
apparent from the present studies that
pretreatment with allogeneic tumour may
enhance the cytostatic effect of peritoneal
exudate cells without suppressing the
development of tumour metastases. It is
apparent, therefore, that further studies
will be necessary to (a) explain these
divergent effects; (b) elucidate their cellu-
lar and molecular basis; (c) establish
their relative importance with respect to
the initial phases of tumour growth; and
(d) to identify and characterize the
tumour products which modulate the
host response to tumours. Finally it must
be emphasized that such studies should
be performed with tumours which are
free (as far as can be reasonably as-
certained) from contamination withviruses
and other micro-organisms which are
known to influence the function of cells
of the lymphoreticular system.
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